Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1971 1
1972 2
1973 1
1974 1
1975 3
1976 9
1977 4
1978 5
1979 4
1980 2
1981 9
1982 4
1983 6
1984 6
1985 10
1986 8
1987 8
1988 4
1989 7
1990 9
1991 6
1992 10
1993 7
1994 13
1995 21
1996 15
1997 11
1998 10
1999 7
2000 7
2001 9
2002 10
2003 9
2004 5
2005 8
2006 6
2007 7
2008 4
2009 10
2010 6
2011 5
2012 6
2013 4
2014 4
2015 6
2016 8
2017 7
2018 4
2019 3
2020 6
2021 6
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

325 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Acute myeloid leukemia, M6 type"
Page 1
Gene methylation in gastric cancer.
Qu Y, Dang S, Hou P. Qu Y, et al. Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10. Clin Chim Acta. 2013. PMID: 23669186 Free article. Review.
Erythroleukemia: an Update.
Weinberg OK, Arber DA. Weinberg OK, et al. Curr Oncol Rep. 2021 Apr 20;23(6):69. doi: 10.1007/s11912-021-01060-8. Curr Oncol Rep. 2021. PMID: 33876292 Review.
PURPOSE OF THE REVIEW: Acute erythroleukemia (AEL) is a rare form of acute myeloid leukemia recognized by erythroblastic proliferation. ...Primary acute erythroid leukemia is associated with complex and high-risk karyotypes includi …
PURPOSE OF THE REVIEW: Acute erythroleukemia (AEL) is a rare form of acute myeloid leukemia recognized by ery
Revisiting erythroleukemia.
Arber DA. Arber DA. Curr Opin Hematol. 2017 Mar;24(2):146-151. doi: 10.1097/MOH.0000000000000314. Curr Opin Hematol. 2017. PMID: 27875373 Review.
PURPOSE OF REVIEW: The 2016 WHO classification of hematopoietic and lymphoid neoplasms alters the diagnostic criteria for erythroleukemia, including eliminating the erythroid/myeloid type of acute erythroleukemia, which was a prior subcategory of acute
PURPOSE OF REVIEW: The 2016 WHO classification of hematopoietic and lymphoid neoplasms alters the diagnostic criteria for erythroleukemia, i …
m6A-driven SF3B1 translation control steers splicing to direct genome integrity and leukemogenesis.
Cieśla M, Ngoc PCT, Muthukumar S, Todisco G, Madej M, Fritz H, Dimitriou M, Incarnato D, Hellström-Lindberg E, Bellodi C. Cieśla M, et al. Mol Cell. 2023 Apr 6;83(7):1165-1179.e11. doi: 10.1016/j.molcel.2023.02.024. Epub 2023 Mar 20. Mol Cell. 2023. PMID: 36944332 Free article.
Although tumorigenic SF3B1 mutations have been extensively characterized, the role of "non-mutated" wild-type SF3B1 in cancer remains largely unresolved. Here, we identify a conserved epitranscriptomic program that steers SF3B1 levels to counteract leukemogenesis. ...This …
Although tumorigenic SF3B1 mutations have been extensively characterized, the role of "non-mutated" wild-type SF3B1 in cancer remains …
Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Bennett JM, et al. Br J Haematol. 1976 Aug;33(4):451-8. doi: 10.1111/j.1365-2141.1976.tb03563.x. Br J Haematol. 1976. PMID: 188440
The slides were examined first independently, and then by the group working together. Two groups of acute leukaemia, 'lymphoblastic' and myeloid are further subdivided into three and six groups. Dysmyelopoietic syndromes that may be confused with acute mye
The slides were examined first independently, and then by the group working together. Two groups of acute leukaemia, 'lymphoblastic' …
Erythroid proliferations in myeloid neoplasms.
Wang SA, Hasserjian RP. Wang SA, et al. Hum Pathol. 2012 Feb;43(2):153-64. doi: 10.1016/j.humpath.2011.08.008. Epub 2011 Dec 9. Hum Pathol. 2012. PMID: 22154053 Review.
The myeloproliferative neoplasm polycythemia vera exhibits effective, overexuberant erythropoiesis resulting in an increased red blood cell mass; in contrast, most other diseases characterized by erythroid predominance exhibit ineffective hemopoiesis. The latter include acute
The myeloproliferative neoplasm polycythemia vera exhibits effective, overexuberant erythropoiesis resulting in an increased red blood cell …
Therapy-related acute myeloid leukemia following treatment of lymphoid malignancies.
Bertoli S, Sterin A, Tavitian S, Oberic L, Ysebaert L, Bouabdallah R, Vergez F, Sarry A, Bérard E, Huguet F, Laurent G, Prébet T, Vey N, Récher C. Bertoli S, et al. Oncotarget. 2016 Dec 27;7(52):85937-85947. doi: 10.18632/oncotarget.13262. Oncotarget. 2016. PMID: 27852053 Free PMC article.
Therapy-related acute myeloid leukemia (t-AML) is a heterogeneous entity most frequently related to breast cancer or lymphoproliferative diseases (LD). ...The aim of this study was to describe the characteristics and outcome of 80 consecutive cases of t-AML f …
Therapy-related acute myeloid leukemia (t-AML) is a heterogeneous entity most frequently related to breast cancer or ly …
Acute megakaryoblastic leukemia, unlike acute erythroid leukemia, predicts an unfavorable outcome after allogeneic HSCT.
Ishiyama K, Yamaguchi T, Eto T, Ohashi K, Uchida N, Kanamori H, Fukuda T, Miyamura K, Inoue Y, Taguchi J, Mori T, Iwato K, Morishima Y, Nagamura-Inoue T, Atsuta Y, Sakamaki H, Takami A. Ishiyama K, et al. Leuk Res. 2016 Aug;47:47-53. doi: 10.1016/j.leukres.2016.04.017. Epub 2016 May 12. Leuk Res. 2016. PMID: 27244257
Acute erythroid leukemia (FAB-M6) and acute megakaryoblastic leukemia (FAB-M7) exhibit closely related properties in cells regarding morphology and the gene expression profile. ...These findings substantiate the importance of distinguishing betw
Acute erythroid leukemia (FAB-M6) and acute megakaryoblastic leukemia (FAB-M7) exhibit closely related pr
Myeloproliferative diseases in childhood.
Nix WL, Fernbach DJ. Nix WL, et al. Am J Pediatr Hematol Oncol. 1981 Winter;3(4):397-407. Am J Pediatr Hematol Oncol. 1981. PMID: 6174053 Review.
Twenty-seven patients with myeloproliferative diseases were treated, six with the juvenile type of chronic myelogenous leukemia (CML), 10 with the adult type of CML, three with familial MPD, one with unclassifiable MPD, and seven with acute leukemia
Twenty-seven patients with myeloproliferative diseases were treated, six with the juvenile type of chronic myelogenous leukemia
Genomic subtyping and therapeutic targeting of acute erythroleukemia.
Iacobucci I, Wen J, Meggendorfer M, Choi JK, Shi L, Pounds SB, Carmichael CL, Masih KE, Morris SM, Lindsley RC, Janke LJ, Alexander TB, Song G, Qu C, Li Y, Payne-Turner D, Tomizawa D, Kiyokawa N, Valentine M, Valentine V, Basso G, Locatelli F, Enemark EJ, Kham SKY, Yeoh AEJ, Ma X, Zhou X, Sioson E, Rusch M, Ries RE, Stieglitz E, Hunger SP, Wei AH, To LB, Lewis ID, D'Andrea RJ, Kile BT, Brown AL, Scott HS, Hahn CN, Marlton P, Pei D, Cheng C, Loh ML, Ebert BL, Meshinchi S, Haferlach T, Mullighan CG. Iacobucci I, et al. Nat Genet. 2019 Apr;51(4):694-704. doi: 10.1038/s41588-019-0375-1. Epub 2019 Mar 29. Nat Genet. 2019. PMID: 30926971 Free PMC article.
Acute erythroid leukemia (AEL) is a high-risk leukemia of poorly understood genetic basis, with controversy regarding diagnosis in the spectrum of myelodysplasia and myeloid leukemia. ...This genomic landscape of AEL provides the framework for a
Acute erythroid leukemia (AEL) is a high-risk leukemia of poorly understood genetic basis, with controversy regarding d
325 results